沉默脂肪细胞增强子结合蛋白2通过PI3K/Akt途径抑

作者：杨超月

[1] Chen Z, Xie H, Hu M, et al. Recent progress in treatment of hepatocellular carcinoma[J]. Am J Cancer Res, 2020, 10(9): 2993-3036
[2] Lin J, Lin W, Ye Y, et al. Kindlin-2 promotes hepatocellular carcinoma invasion and metastasis by increasing Wnt/β-catenin signaling[J]. J Exp Clin Cancer Res, 2017, 36(1): 134
[3] 湛钊, 周莉莉, 高义沙, 等. shRNA沉默HuR抑制肝细胞癌细胞系SMMC-7721的增殖、迁移及侵袭能力[J]. 中国生物化学与分子生物学报 (Zhan Z, Zhou LL, Gao YS, et al. shRNA silencing HuR inhibits proliferation, migration and invasion of SMMC-7721 hepatocellular carcinoma cells[J]. Chin J Biochem Mol Biol), 2020, 36(8): 952-960
[4] Jiang H, Zhou Z, Jin S, et al. PRMT9 promotes hepatocellular carcinoma invasion and metastasis via activating PI3K/Akt/GSK-3β/Snail signaling[J]. Cancer Sci, 2018, 109(5): 1414-1427
[5] Jin J, Wang SJ, Cui J, et al. Hypo-phosphorylated CD147 promotes migration and invasion of hepatocellular carcinoma cells and predicts a poor prognosis[J]. Cell Oncol (Dordr), 2019, 42(4): 537-554
[6] Kim H, Kang K, Ekram MB, et al. Aebp2 as an epigenetic regulator for neural crest cells[J]. PLoS One, 2011, 6(9): e25174
[7] Kim H, Kang K, Kim J. AEBP2 as a potential targeting protein for Polycomb Repression Complex PRC2[J]. Nucleic Acids Res, 2009, 37(9): 2940-2950
[8] Zhang Q, Wang W, Gao Q. β-TRCP-mediated AEBP2 ubiquitination and destruction controls cisplatin resistance in ovarian cancer[J]. Biochem Biophys Res Commun, 2020, 523(1): 274-279
[9] Zhang X, Cong L, Xu D, et al. AC092127.1-miR-451a-AE binding protein 2 signaling facilitates malignant properties of breast cancer[J]. J Breast Cancer, 2021, 24(4): 389-401
[10] Kim H, Ekram MB, Bakshi A, et al. AEBP2 as a transcriptional activator and its role in cell migration[J]. Genomics, 2015, 105(2): 108-115
[11] Wang J, He H, Jiang Q, et al. CBX6 Promotes HCC metastasis via transcription factors Snail/Zeb1-mediated EMT mechanism[J]. Onco Targets Ther, 2020, 13: 12489-12500
[12] Gu X, Mao Y, Shi C, et al. MAGEC2 correlates with unfavorable prognosis and promotes tumor development in HCC via epithelial-mesenchymal transition[J]. Onco Targets Ther, 2019, 12: 7843- 7855
[13] Zhang H, Tang QF, Sun MY, et al. ARHGAP9 suppresses the migration and invasion of hepatocellular carcinoma cells through up-regulating FOXJ2/E-cadherin[J]. Cell Death Dis, 2018, 9(9): 916
[14] Wu C, Qi X, Qiu Z, et al. Low expression of KIF20A suppresses cell proliferation, promotes chemosensitivity and is associated with better prognosis in HCC[J]. Aging (Albany NY), 2021, 13(18): 22148-22163
[15] Yao J, Fu J, Liu Y, et al. LncRNA CASC9 promotes proliferation, migration and inhibits apoptosis of hepatocellular carcinoma cells by down-regulating miR-424-5p[J]. Ann Hepatol, 2021, 23: 100297
[16] Van Mierlo G, Veenstra G J C, Vermeulen M, et al. The complexity of PRC2 subcomplexes [J]. Trends Cell Biol, 2019, 29(8): 660-671
[17] Yan J, Dutta B, Hee YT, et al. Towards understanding of PRC2 binding to RNA[J]. RNA Biol, 2019, 16(2): 176-184
[18] Zhang DY, Sun QC, Zou XJ, et al. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2[J]. J Exp Clin Cancer Res, 2020, 39(1): 229
[19] Xue C, Wang K, Jiang X, et al. The down-regulation of SUZ12 accelerates the migration and invasion of liver cancer cells via activating ERK1/2 pathway[J]. J Cancer, 2019, 10(6): 1375-1384
[20] Gao X, Wang X, Zhang S. Bioinformatics identification of crucial genes and pathways associated with hepatocellular carcinoma[J]. Biosci Rep, 2018, 38(6): BSR20181441
[21] Gong C, Ai J, Fan Y, et al. NCAPG promotes the proliferation of hepatocellular carcinoma through PI3K/AKT signaling[J]. Onco Targets Ther, 2019, 12: 8537-8552
[22] 炎士珂, 冯婧文, 昌娇, 等. FGFC1经PI3K/Akt/mTOR途径抑制非小细胞肺癌细胞增殖和迁移[J]. 中国生物化学与分子生物学报 (Yan SK, Feng JW, Chang J, et al. FGFC1 inhibits proliferation and migration of non-small cell lung cancer cells via the PI3K/Akt/mTOR signaling pathway[J]. Chin J Biochem Mol Biol), 2021, 37(8): 1069-1077
[23] Li H, Zhang Y, Hai J, et al. Knockdown of TRIM31 suppresses proliferation and invasion of gallbladder cancer cells by down-regulating MMP2/9 through the PI3K/Akt signaling pathway[J]. Biomed Pharmacother, 2018, 103: 1272-1278
[24] Ma Z, Lou S, Jiang Z. PHLDA2 regulates EMT and autophagy in colorectal cancer via the PI3K/AKT signaling pathway[J]. Aging (Albany NY), 2020, 12(9): 7985-8000
[25] Peng Y, Li F, Zhang P, et al. IGF-1 promotes multiple myeloma progression through PI3K/Akt-mediated epithelial-mesenchymal transition[J]. Life Sci, 2020, 249: 117503